Teleperformance SE shares tumbled 13.4% to €45.03, establishing a new 52-week low, after Concentrix pared back its full-year 2026 outlook. Concentrix lowered revenue guidance to $9.93–$10.03 billion from $10.04–$10.18 billion and trimmed adjusted profit guidance to $10.83–$11.18 per share from $11.48–$12.07, prompting analysts to warn that the move signals stress across the business process outsourcing sector.
Concentrix also adjusted its third-quarter revenue outlook to $2.47–$2.49 billion, beneath the $2.53 billion analyst consensus, following a second-quarter revenue print of $2.46 billion that likewise missed expectations. Those guidance revisions served as the immediate catalyst for selling in Teleperformance, where investors reacted to the prospect of broader client pressure weighing on demand for contact-center services.
Technical indicators had already been pointing to vulnerability in Teleperformance's share price. A technical analysis published on June 29 flagged that the stock was trading well below its 50-day moving average, displayed a negative MACD, carried bearish stochastic readings, and had a key support reference near €45.56. The market moved decisively through that threshold in today's session.
Further pressure on sentiment had been building after Morgan Stanley reduced its price target to €53 and warned of expected negative organic revenue growth in early 2026. That caution was reflected in Teleperformance's Q1 2026 top line, which came in at €2.433 billion, a like-for-like decline of 2.2% and below the company's own full-year guidance range of 0–2% growth.
Macro and market dynamics offered little relief. The French CAC 40 and SBF 120, Teleperformance’s reference index, were both under recent pressure amid global technology sector concerns and soft domestic economic data, removing any immediate market tailwind for the stock.
Structurally, peers in the BPO and customer-experience outsourcing arena, including Concentrix and Conduent, are contending with the same narrative: AI-powered automation is increasingly viewed as a potential substitute for the human-staffed contact-center services that underpin much of Teleperformance's revenue model. That evolving competitive backdrop, combined with the aforementioned technical and fundamental weaknesses, helped create the conditions for an outsized selloff.
With the share price now down more than 50% from its 52-week high of €90.72 and trading at a new cycle low, market sentiment around Teleperformance remains deeply negative. Investors appeared reluctant to re-enter positions ahead of the company’s next scheduled earnings release on July 30, 2026.
Contextual note: The recent move was triggered by Concentrix's guidance revisions and amplified by pre-existing technical weakness, continued concerns about AI disruption in contact-center services, and an absence of positive corporate catalysts on the day of the decline.